Black Rock Inc. Chroma Dex Corp. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Chroma Dex Corp. stock. As of the latest transaction made, Black Rock Inc. holds 3,116,178 shares of CDXC stock, worth $16.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,116,178
Previous 902,953
245.11%
Holding current value
$16.9 Million
Previous $3.14 Million
170.75%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CDXC
# of Institutions
129Shares Held
21.9MCall Options Held
203KPut Options Held
23.9K-
Vanguard Group Inc Valley Forge, PA3.39MShares$18.4 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.59MShares$14 Million5.52% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$7.03 Million0.14% of portfolio
-
Geode Capital Management, LLC Boston, MA1.15MShares$6.26 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.01MShares$5.48 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $370M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...